OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
5.21
+0.06 (1.17%)
Nov 4, 2024, 4:00 PM EST - Market closed
OptimizeRx Employees
As of December 31, 2023, OptimizeRx had 136 total employees, including 135 full-time and 1 part-time employees. The number of employees increased by 26 or 23.64% compared to the previous year.
Employees
136
Change (1Y)
26
Growth (1Y)
23.64%
Revenue / Employee
$611,783
Profits / Employee
-$131,727
Market Cap
95.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FONAR | 561 |
MDxHealth | 300 |
Protalix BioTherapeutics | 208 |
CASI Pharmaceuticals | 176 |
BioAtla | 65 |
InflaRx | 62 |
Renovaro | 25 |
Genenta Science | 14 |
OPRX News
- 4 days ago - OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 7 weeks ago - OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - GlobeNewsWire
- 2 months ago - OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - GlobeNewsWire
- 3 months ago - OptimizeRx Corporation (OPRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 3 months ago - OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation - GlobeNewsWire
- 4 months ago - OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients - GlobeNewsWire
- 4 months ago - New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations - GlobeNewsWire